Itau Unibanco Holding S.A.’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.29M | Buy |
4,663
+1,702
| +57% | +$1.73M | 0.1% | 81 |
|
|
2025
Q4 | $3.2M | Sell |
2,961
-101
| -3% | -$96.6K | 0.08% | 95 |
|
|
2025
Q3 | $2.34M | Buy |
3,062
+3,008
| +5,570% | +$2.24M | 0.08% | 91 |
|
|
2025
Q2 | $42.1K | Hold |
54
| – | – | ﹤0.01% | 275 |
|
|
2025
Q1 | $45K | Sell |
54
-1
| -2% | -$832 | ﹤0.01% | 278 |
|
|
2024
Q4 | $42.5K | Sell |
55
-37
| -40% | -$30.6K | ﹤0.01% | 268 |
|
|
2024
Q3 | $81.5K | Sell |
92
-2,714
| -97% | -$2.44M | ﹤0.01% | 157 |
|
|
2024
Q2 | $2.54M | Buy |
+2,806
| New | +$2.24M | 0.1% | 80 |
|
|
2024
Q1 | – | Sell |
-107
| Closed | -$62.4K | – | 260 |
|
|
2023
Q4 | $62.4K | Sell |
107
-57
| -35% | -$33.3K | ﹤0.01% | 209 |
|
|
2023
Q3 | $88.1K | Sell |
164
-1
| -0.6% | -$515 | ﹤0.01% | 214 |
|
|
2023
Q2 | $77.4K | Buy |
+165
| New | +$69.2K | ﹤0.01% | 260 |
|
|
2023
Q1 | – | Sell |
-166
| Closed | -$60.7K | – | 569 |
|
|
2022
Q4 | $60.7K | Sell |
166
-43
| -21% | -$15.2K | ﹤0.01% | 332 |
|
|
2022
Q3 | $68K | Sell |
209
-13,532
| -98% | -$4.29M | ﹤0.01% | 365 |
|
|
2022
Q2 | $4.46M | Buy |
13,741
+13,428
| +4,290% | +$4.03M | 0.16% | 82 |
|
|
2022
Q1 | $90K | Sell |
313
-1
| -0.3% | -$257 | ﹤0.01% | 274 |
|
|
2021
Q4 | $87K | Sell |
314
-10
| -3% | -$2.54K | ﹤0.01% | 228 |
|
|
2021
Q3 | $75K | Buy |
324
+112
| +53% | +$27.6K | ﹤0.01% | 216 |
|
|
2021
Q2 | $49K | Buy |
+212
| New | +$42.6K | ﹤0.01% | 174 |
|
|
2020
Q1 | – | Sell |
-1,289
| Closed | -$169K | – | 657 |
|
|
2019
Q4 | $169K | Buy |
+1,289
| New | +$149K | 0.01% | 311 |
|
|
2019
Q3 | – | Sell |
-5,026
| Closed | -$557K | – | 516 |
|
|
2019
Q2 | $557K | Buy |
5,026
+4,064
| +422% | +$479K | 0.03% | 235 |
|
|
2019
Q1 | $110K | Hold |
962
| – | – | 0.01% | 345 |
|
|
2018
Q4 | $110K | Buy |
+962
| New | +$107K | 0.01% | 345 |
|
|
2018
Q3 | – | Sell |
-514
| Closed | -$44K | – | 707 |
|
|
2018
Q2 | $44K | Sell |
514
-3,839
| -88% | -$315K | ﹤0.01% | 628 |
|
|
2018
Q1 | $337K | Sell |
4,353
-1,439
| -25% | -$116K | ﹤0.01% | 280 |
|
|
2017
Q4 | $489K | Buy |
5,792
+2,431
| +72% | +$207K | 0.03% | 172 |
|
|
2017
Q3 | $910K | Sell |
3,361
-3,149
| -48% | -$258K | 0.06% | 183 |
|
|
2017
Q2 | $536K | Buy |
6,510
+5,888
| +947% | +$480K | 0.06% | 106 |
|
|
2017
Q1 | $52K | Buy |
+622
| New | +$49.8K | 0.01% | 195 |
|
Other funds holding LLY
VCM
VPM
Itau Unibanco Holding S.A.'s LLY Position: Q1 2026 in Review
Itau Unibanco Holding S.A. increased its Eli Lilly (LLY) stake by 57% in Q1 2026, buying an estimated $1.73M and bringing the position to 4,663 shares worth $4.29M. The position accounts for 0.1% of the portfolio, ranked #81.
Itau Unibanco Holding S.A. first reported a position in LLY in Q1 2017 and has held it in 28 quarters since. The position peaked at $4.46M in Q2 2022. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Itau Unibanco Holding S.A. held 4,663 shares of Eli Lilly worth $4.29M as of Q1 2026.
- Itau Unibanco Holding S.A. bought 1,702 Eli Lilly shares in Q1 2026, an estimated $1.73M.
- Eli Lilly made up 0.1% of Itau Unibanco Holding S.A.'s portfolio in Q1 2026, its #81 holding.
- Itau Unibanco Holding S.A. first reported a position in Eli Lilly in Q1 2017 and has held it in 28 quarters since.
- Itau Unibanco Holding S.A.'s Eli Lilly position peaked at $4.46M in Q2 2022.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2026, filed 14 May 2026.